Fibrinogen interaction with platelets of diabetic subjects

Stefan Niewiarowski, Razia Rawala, Hanna Lukasiewicz, Diane Hershock, Anna M. Capitanio, Elizabeth Kornecki, Gunther Roden

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Fibrinogen-platelet interaction was studied in suspensions of platelets obtained from patients with uncontrolled diabetes mellitus of long duration and from control individuals. Fibrinogen binding sites were exposed by stimulating platelets with ADP or with chymotrypsin. There was no significant difference in fibrinogen mediated aggregation between ADP-stimulated platelets of 80 control and 47 diabetic subjects. The Km values for fibrinogen mediated aggregation of ADP-stimulated platelets obtained from control and diabetic donors were 1.39 ± 0.13 × 10-7M and 1.44 ± 0.13 × 10-7M; the Vmax values (expressed in arbitrary-light transmission units) were 87.8 ± 3.14 and 92.8 ± 4.5 (mean ± S.E.M.). The analysis of variance showed no significant relationship between Km, Vmax, age and sex in control group; in patient group there was no significant relationship between Km, Vmax, age, sex, type of diabetes, presence of vascular complications and type of treatment (insulin and/or oral hypoglycemic agents). Fibrinogen mediated aggregation of chymotrypsin-treated platelets showed similar pattern in 25 control and in 25 diabetic donors. In 24 normal individuals and in 24 diabetic patients Scatchard analysis revealed 48,820 ± 5350 fibrinogen binding sites per one normal platelet (Kd = 4.7 × 10-7M) and 45,350 ± 4663 sites per one diabetic platelet (Kd = 3.5 × 10-7M). Our data suggest a normal pattern of interaction between fibrinogen and fully activated platelets of diabetic subjects.

Original languageEnglish (US)
Pages (from-to)479-489
Number of pages11
JournalThrombosis Research
Volume46
Issue number3
DOIs
StatePublished - May 1 1987

Fingerprint

Fibrinogen
Blood Platelets
Adenosine Diphosphate
Chymotrypsin
Binding Sites
Tissue Donors
Hypoglycemic Agents
Blood Vessels
Suspensions
Diabetes Mellitus
Analysis of Variance
Insulin
Light
Control Groups

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Niewiarowski, S., Rawala, R., Lukasiewicz, H., Hershock, D., Capitanio, A. M., Kornecki, E., & Roden, G. (1987). Fibrinogen interaction with platelets of diabetic subjects. Thrombosis Research, 46(3), 479-489. https://doi.org/10.1016/0049-3848(87)90135-6
Niewiarowski, Stefan ; Rawala, Razia ; Lukasiewicz, Hanna ; Hershock, Diane ; Capitanio, Anna M. ; Kornecki, Elizabeth ; Roden, Gunther. / Fibrinogen interaction with platelets of diabetic subjects. In: Thrombosis Research. 1987 ; Vol. 46, No. 3. pp. 479-489.
@article{bb5ab940a2d14e3a8464f863a2c001a6,
title = "Fibrinogen interaction with platelets of diabetic subjects",
abstract = "Fibrinogen-platelet interaction was studied in suspensions of platelets obtained from patients with uncontrolled diabetes mellitus of long duration and from control individuals. Fibrinogen binding sites were exposed by stimulating platelets with ADP or with chymotrypsin. There was no significant difference in fibrinogen mediated aggregation between ADP-stimulated platelets of 80 control and 47 diabetic subjects. The Km values for fibrinogen mediated aggregation of ADP-stimulated platelets obtained from control and diabetic donors were 1.39 ± 0.13 × 10-7M and 1.44 ± 0.13 × 10-7M; the Vmax values (expressed in arbitrary-light transmission units) were 87.8 ± 3.14 and 92.8 ± 4.5 (mean ± S.E.M.). The analysis of variance showed no significant relationship between Km, Vmax, age and sex in control group; in patient group there was no significant relationship between Km, Vmax, age, sex, type of diabetes, presence of vascular complications and type of treatment (insulin and/or oral hypoglycemic agents). Fibrinogen mediated aggregation of chymotrypsin-treated platelets showed similar pattern in 25 control and in 25 diabetic donors. In 24 normal individuals and in 24 diabetic patients Scatchard analysis revealed 48,820 ± 5350 fibrinogen binding sites per one normal platelet (Kd = 4.7 × 10-7M) and 45,350 ± 4663 sites per one diabetic platelet (Kd = 3.5 × 10-7M). Our data suggest a normal pattern of interaction between fibrinogen and fully activated platelets of diabetic subjects.",
author = "Stefan Niewiarowski and Razia Rawala and Hanna Lukasiewicz and Diane Hershock and Capitanio, {Anna M.} and Elizabeth Kornecki and Gunther Roden",
year = "1987",
month = "5",
day = "1",
doi = "10.1016/0049-3848(87)90135-6",
language = "English (US)",
volume = "46",
pages = "479--489",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "3",

}

Niewiarowski, S, Rawala, R, Lukasiewicz, H, Hershock, D, Capitanio, AM, Kornecki, E & Roden, G 1987, 'Fibrinogen interaction with platelets of diabetic subjects', Thrombosis Research, vol. 46, no. 3, pp. 479-489. https://doi.org/10.1016/0049-3848(87)90135-6

Fibrinogen interaction with platelets of diabetic subjects. / Niewiarowski, Stefan; Rawala, Razia; Lukasiewicz, Hanna; Hershock, Diane; Capitanio, Anna M.; Kornecki, Elizabeth; Roden, Gunther.

In: Thrombosis Research, Vol. 46, No. 3, 01.05.1987, p. 479-489.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fibrinogen interaction with platelets of diabetic subjects

AU - Niewiarowski, Stefan

AU - Rawala, Razia

AU - Lukasiewicz, Hanna

AU - Hershock, Diane

AU - Capitanio, Anna M.

AU - Kornecki, Elizabeth

AU - Roden, Gunther

PY - 1987/5/1

Y1 - 1987/5/1

N2 - Fibrinogen-platelet interaction was studied in suspensions of platelets obtained from patients with uncontrolled diabetes mellitus of long duration and from control individuals. Fibrinogen binding sites were exposed by stimulating platelets with ADP or with chymotrypsin. There was no significant difference in fibrinogen mediated aggregation between ADP-stimulated platelets of 80 control and 47 diabetic subjects. The Km values for fibrinogen mediated aggregation of ADP-stimulated platelets obtained from control and diabetic donors were 1.39 ± 0.13 × 10-7M and 1.44 ± 0.13 × 10-7M; the Vmax values (expressed in arbitrary-light transmission units) were 87.8 ± 3.14 and 92.8 ± 4.5 (mean ± S.E.M.). The analysis of variance showed no significant relationship between Km, Vmax, age and sex in control group; in patient group there was no significant relationship between Km, Vmax, age, sex, type of diabetes, presence of vascular complications and type of treatment (insulin and/or oral hypoglycemic agents). Fibrinogen mediated aggregation of chymotrypsin-treated platelets showed similar pattern in 25 control and in 25 diabetic donors. In 24 normal individuals and in 24 diabetic patients Scatchard analysis revealed 48,820 ± 5350 fibrinogen binding sites per one normal platelet (Kd = 4.7 × 10-7M) and 45,350 ± 4663 sites per one diabetic platelet (Kd = 3.5 × 10-7M). Our data suggest a normal pattern of interaction between fibrinogen and fully activated platelets of diabetic subjects.

AB - Fibrinogen-platelet interaction was studied in suspensions of platelets obtained from patients with uncontrolled diabetes mellitus of long duration and from control individuals. Fibrinogen binding sites were exposed by stimulating platelets with ADP or with chymotrypsin. There was no significant difference in fibrinogen mediated aggregation between ADP-stimulated platelets of 80 control and 47 diabetic subjects. The Km values for fibrinogen mediated aggregation of ADP-stimulated platelets obtained from control and diabetic donors were 1.39 ± 0.13 × 10-7M and 1.44 ± 0.13 × 10-7M; the Vmax values (expressed in arbitrary-light transmission units) were 87.8 ± 3.14 and 92.8 ± 4.5 (mean ± S.E.M.). The analysis of variance showed no significant relationship between Km, Vmax, age and sex in control group; in patient group there was no significant relationship between Km, Vmax, age, sex, type of diabetes, presence of vascular complications and type of treatment (insulin and/or oral hypoglycemic agents). Fibrinogen mediated aggregation of chymotrypsin-treated platelets showed similar pattern in 25 control and in 25 diabetic donors. In 24 normal individuals and in 24 diabetic patients Scatchard analysis revealed 48,820 ± 5350 fibrinogen binding sites per one normal platelet (Kd = 4.7 × 10-7M) and 45,350 ± 4663 sites per one diabetic platelet (Kd = 3.5 × 10-7M). Our data suggest a normal pattern of interaction between fibrinogen and fully activated platelets of diabetic subjects.

UR - http://www.scopus.com/inward/record.url?scp=0023192423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023192423&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(87)90135-6

DO - 10.1016/0049-3848(87)90135-6

M3 - Article

C2 - 3603436

AN - SCOPUS:0023192423

VL - 46

SP - 479

EP - 489

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 3

ER -

Niewiarowski S, Rawala R, Lukasiewicz H, Hershock D, Capitanio AM, Kornecki E et al. Fibrinogen interaction with platelets of diabetic subjects. Thrombosis Research. 1987 May 1;46(3):479-489. https://doi.org/10.1016/0049-3848(87)90135-6